See more : Audioboom Group plc (BOOM.L) Income Statement Analysis – Financial Results
Complete financial analysis of S2Medical AB (publ) (S2M.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of S2Medical AB (publ), a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Globavend Holdings Limited (GVH) Income Statement Analysis – Financial Results
- Brookfield Asset Management Inc (BKFAF) Income Statement Analysis – Financial Results
- American Racing Capital, Inc. (AMRA) Income Statement Analysis – Financial Results
- Bit Brother Limited (BTB) Income Statement Analysis – Financial Results
- Brookfield Infrastructure Corpo (BIPH) Income Statement Analysis – Financial Results
S2Medical AB (publ) (S2M.ST)
About S2Medical AB (publ)
S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers INSTAQRETT, a sterile single use mechanical debridement tool; EPIPROTECT SafeStop for blood stilling; Instagraft, a single-use medical device for the treatment of chronic and complicated wounds; EPIPROTECT tissue substitutes; and washable, waterproof, and self-adhesive bandages under the INSTABIND brand name. The company also distributes Silverlon dressings that deliver silver ions into the wound. In addition, it operates wound healing center under the S2Clinic name. The company was founded in 2013 and is headquartered in Linköping, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.97M | 4.67M | 7.70M | 25.62M | 3.10M | 1.50M | 844.00K | 340.00K | 1.53M |
| Cost of Revenue | 1.93M | -494.85K | 602.80K | 15.57M | -804.55K | -3.27M | -1.05M | -2.24M | 689.93K |
| Gross Profit | 5.04M | 5.17M | 7.10M | 10.05M | 3.90M | 4.77M | 1.90M | 2.58M | 844.60K |
| Gross Profit Ratio | 72.25% | 110.60% | 92.17% | 39.23% | 125.97% | 318.90% | 224.76% | 758.24% | 55.04% |
| Research & Development | 606.11K | 594.90K | 385.34K | 383.74K | 383.74K | 383.74K | 383.74K | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 12.21M | 11.12M | 12.11M | 8.40M | 3.68M | 1.92M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 31.54M | 12.21M | 11.12M | 12.11M | 8.40M | 3.68M | 1.92M | 910.46K |
| Other Expenses | 19.69M | 32.85M | 14.73M | 13.86M | 10.12M | 6.98M | 3.44M | 1.71M | 0.00 |
| Operating Expenses | 20.30M | 32.85M | 26.93M | 24.98M | 22.24M | 15.38M | 7.12M | 3.63M | 773.83K |
| Cost & Expenses | 22.24M | 32.36M | 27.54M | 40.55M | 21.43M | 12.10M | 6.07M | 1.39M | 1.46M |
| Interest Income | 361.00 | 1.77M | 243.41K | 45.00 | 45.00 | 0.00 | 60.00 | 0.00 | 67.97K |
| Interest Expense | 7.44M | 1.77M | 243.41K | 73.05K | 101.29K | 124.27K | 153.00K | 147.00K | 0.00 |
| Depreciation & Amortization | 1.73M | 1.32M | 1.11M | 922.34K | 883.33K | 824.64K | 651.45K | 222.81K | 71.12K |
| EBITDA | -13.53M | -26.37M | -18.73M | -14.14M | -17.45M | -9.78M | -4.57M | -825.00K | 141.89K |
| EBITDA Ratio | -194.07% | -551.82% | -238.21% | -53.27% | -550.83% | -654.05% | -541.82% | -242.65% | 9.25% |
| Operating Income | -15.26M | -27.69M | -19.84M | -14.94M | -18.33M | -10.61M | -5.22M | -1.05M | 70.77K |
| Operating Income Ratio | -218.95% | -592.88% | -257.62% | -58.31% | -591.73% | -709.19% | -618.96% | -308.24% | 4.61% |
| Total Other Income/Expenses | -7.44M | -1.77M | -243.41K | -73.00K | -101.25K | -124.27K | -153.12K | -147.00K | -67.97K |
| Income Before Tax | -22.71M | -29.46M | -20.08M | -15.01M | -18.44M | -10.73M | -5.38M | -1.20M | 2.80K |
| Income Before Tax Ratio | -325.73% | -630.73% | -260.78% | -58.59% | -595.00% | -717.50% | -637.09% | -351.47% | 0.18% |
| Income Tax Expense | 0.00 | 1.77M | 243.41K | 73.05K | 101.29K | 663.50K | -1.00K | -1.00K | 0.00 |
| Net Income | -22.71M | -31.22M | -20.32M | -15.08M | -18.54M | -10.73M | -5.38M | -1.20M | 2.80K |
| Net Income Ratio | -325.73% | -668.58% | -263.94% | -58.88% | -598.27% | -717.50% | -637.09% | -351.47% | 0.18% |
| EPS | -0.14 | -0.45 | -0.35 | -0.33 | -0.40 | -0.23 | -0.21 | -0.03 | 0.00 |
| EPS Diluted | -0.14 | -0.45 | -0.35 | -0.33 | -0.40 | -0.23 | -0.21 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 157.67M | 68.90M | 58.23M | 46.07M | 46.38M | 46.38M | 25.66M | 36.12M | 0.00 |
| Weighted Avg Shares Out (Dil) | 157.67M | 68.90M | 58.23M | 46.07M | 46.38M | 46.38M | 25.66M | 36.12M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports